Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Ann R. Klee is Director at Sotera Health. OQRO lists 2 transactions filed with the SEC under this name, the latest on May 28, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
2
Ann R. Klee has no open-market purchase on record since 2024. Sales in 1 of the 3 years since 2024.
Ann R. Klee reported 0 open-market purchases and 1 sale since 2024; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $82K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
May 22, 202615Kdisclosed May 28
DetailsOfficial recordWabtecWAB
May 13, 2026765disclosed May 15
DetailsOfficial recordAs of the latest filing on , Ann R. Klee reported holding 12,574 shares of Wabtec (WAB), worth about $3.65M at the last close of $291 (Nov 18, 2026). Holdings are also on file at Sotera Health (SHC); together they are worth about $5.95M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Wabtec WAB | 12,574 | 13K direct | $291 | $3.65M | May 13, 2026 |
| Sotera Health SHC | 140,926 | 141K direct | $16 | $2.29M | May 22, 2026 |
Is this Ann R. Klee’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated May 13, 2026, Ann R. Klee reported holding 12,574 shares of Wabtec (WAB). At the last close of $291 on Nov 18, 2026, that is about $3.65M. This is the stake disclosed in filings, not a net worth.
No public filing gives Ann R. Klee's net worth. What SEC Form 4 shows is the stock stake: 12,574 shares of Wabtec (WAB), about $3.65M at the last close, plus holdings in 1 other company, about $5.95M in all. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Ann R. Klee has no open-market purchase on record since 2024. Sales in 1 of the 3 years since 2024.
In SEC filings since 2024: no open-market purchase is on record; the latest open-market sale is from 2024.
Sotera Health (SHC), from 2024 to 2024: 0 purchases and 1 sale.
Ann R. Klee reported 0 open-market purchases and 1 sale here, 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.